Literature DB >> 21385890

Interest of the preliminary risk analysis method in a central sterile supply department.

Juliette Niel-Lainé1, Nicolas Martelli, Brigitte Bonan, Damien Talon, Alain Desroches, Patrice Prognon, Florence Vincent.   

Abstract

OBJECTIVES: In order to improve its quality-assurance programme based on ISO 9001, the Central Sterile Supply Department of a public university hospital has performed a prospective risk analysis using the Preliminary Risk Analysis method (PRA). The objectives were the achievement of a global risk mapping related to the whole process of sterilising medical devices, and second, the implementation of corrective measures to reduce identified risks.
METHODS: A multidisciplinary team, formed in January 2008, validated results at each step of the study. During the analysis, 416 hazardous situations were identified, among which 81 were quoted first in priority and led to the description of 141 risk scenarios. The PRA team assessed 42 scenarios with risk ranking assessed as 'acceptable under control' or 'unacceptable.' They adopted 23 follow-up actions measures and 13 safety parameters. RESULTS AND DISCUSSION: The PRA constitutes an appropriate tool for assessing quality-improvement policy and safety in healthcare facilities that can be easily integrated into standard quality-management systems.

Mesh:

Year:  2011        PMID: 21385890     DOI: 10.1136/bmjqs.2010.048074

Source DB:  PubMed          Journal:  BMJ Qual Saf        ISSN: 2044-5415            Impact factor:   7.035


  2 in total

1.  Use of a risk assessment method to improve the safety of negative pressure wound therapy.

Authors:  Anne-Sophie Lelong; Nicolas Martelli; Brigitte Bonan; Patrice Prognon; Judith Pineau
Journal:  Int Wound J       Date:  2012-08-30       Impact factor: 3.315

Review 2.  Risk Management in Executive Levels of Healthcare Organizations: Insights from a Scoping Review (2018).

Authors:  Masoud Ferdosi; Reza Rezayatmand; Yasamin Molavi Taleghani
Journal:  Risk Manag Healthc Policy       Date:  2020-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.